• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL EPIC¿ VALVE (MITRAL); HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL EPIC¿ VALVE (MITRAL); HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number E100-29M
Device Problems Device Stenosis (4066); Central Regurgitation (4068)
Patient Problems Dyspnea (1816); Mitral Valve Stenosis (1965); Mitral Valve Insufficiency/ Regurgitation (4451)
Event Date 03/15/2024
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Literature attachment: transcatheter mitral valve-in-valve explant: lessons learned.
 
Event Description
The article, "transcatheter mitral valve-in-valve explant: lessons learned", was reviewed.The article presented a case study of a 66-year-old male patient with von willebrand disease.It was reported that on an unknown date, a 29mm epic valve was implanted.It was then reported 10 years post-procedure on an unknown date, the patient presented with dyspnea due to severe mitral regurgitation.A decision was made to perform a transcatheter valve-in-valve procedure with a 26mm sapien valve.It was then reported one year post-intervention, the patient had elevated gradient.A decision was made to surgically remove both 29mm epic valve with the embedded 26mm sapien valve.A 27/29 on-x mechanical valve was then implanted with no adverse patient consequences.The article concluded that mitral valve-in-valve explant is technically feasible.The authors recommended en bloc removal of both valves as the safest method of valve explant.[the primary and corresponding author was mohammad bashir, university of iowa carver college of medicine, department of cardiothoracic surgery, iowa city, iowa 52242, with corresponding email: mohammad-bashir@uiowa.Edu].
 
Manufacturer Narrative
Summarized patient outcomes/complications of epic valve was reported in a research article in a subject population with von willebrand disease.Some of the complications reported were surgical intervention (valve-in-valve, surgical explant), hospitalization, mitral regurgitation, dyspnea and mitral stenosis.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device or individual patient information was received for analysis.
 
Event Description
The article, "transcatheter mitral valve-in-valve explant: lessons learned", was reviewed.The article presented a case study of a 66-year-old male patient with von willebrand disease.It was reported that on an unknown date, a 29mm epic valve was implanted.It was then reported 10 years post-procedure on an unknown date, the patient presented with dyspnea due to severe mitral regurgitation.A decision was made to perform a transcatheter valve-in-valve procedure with a 26mm sapien valve.It was then reported one year post-intervention, the patient had elevated gradient.A decision was made to surgically remove both 29mm epic valve with the embedded 26mm sapien valve.A 27/29 on-x mechanical valve was then implanted with no adverse patient consequences.The article concluded that mitral valve-in-valve explant is technically feasible.The authors recommended en bloc removal of both valves as the safest method of valve explant.[the primary and corresponding author was mohammad bashir, university of iowa carver college of medicine, department of cardiothoracic surgery, iowa city, iowa 52242, with corresponding email: mohammad-bashir@uiowa.Edu].
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC¿ VALVE (MITRAL)
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key19097809
MDR Text Key340038708
Report Number2135147-2024-01668
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberE100-29M
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/18/2024
Initial Date FDA Received04/12/2024
Supplement Dates Manufacturer Received05/17/2024
Supplement Dates FDA Received05/22/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age66 YR
Patient SexMale
-
-